HEADER OXIDOREDUCTASE 04-APR-16 5J6C TITLE FMN-DEPENDENT NITROREDUCTASE (CDR20291_0767) FROM CLOSTRIDIUM TITLE 2 DIFFICILE R20291 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE REDUCTASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PEPTOCLOSTRIDIUM DIFFICILE (STRAIN R20291); SOURCE 3 ORGANISM_TAXID: 645463; SOURCE 4 STRAIN: R20291; SOURCE 5 GENE: CDR20291_0767; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) KEYWDS NITROREDUCTASE, HYPERVIRULENT, METRONIDAZOLE RESISTANCE, KEYWDS 2 OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR S.M.POWELL,B.WANG,N.HESSAMI,F.Z.NAJAR,L.M.THOMAS,A.H.WEST,E.A.KARR, AUTHOR 2 G.B.RICHTER-ADDO REVDAT 4 27-SEP-23 5J6C 1 REMARK REVDAT 3 22-NOV-17 5J6C 1 REMARK REVDAT 2 05-OCT-16 5J6C 1 JRNL REVDAT 1 21-SEP-16 5J6C 0 JRNL AUTH B.WANG,S.M.POWELL,N.HESSAMI,F.Z.NAJAR,L.M.THOMAS,E.A.KARR, JRNL AUTH 2 A.H.WEST,G.B.RICHTER-ADDO JRNL TITL CRYSTAL STRUCTURES OF TWO NITROREDUCTASES FROM HYPERVIRULENT JRNL TITL 2 CLOSTRIDIUM DIFFICILE AND FUNCTIONALLY RELATED INTERACTIONS JRNL TITL 3 WITH THE ANTIBIOTIC METRONIDAZOLE. JRNL REF NITRIC OXIDE V. 60 32 2016 JRNL REFN ESSN 1089-8611 JRNL PMID 27623089 JRNL DOI 10.1016/J.NIOX.2016.09.003 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.94 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 87.7 REMARK 3 NUMBER OF REFLECTIONS : 22352 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.190 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.910 REMARK 3 FREE R VALUE TEST SET COUNT : 1768 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.9506 - 4.9271 0.97 1890 156 0.1769 0.2089 REMARK 3 2 4.9271 - 3.9116 0.97 1784 157 0.1424 0.1685 REMARK 3 3 3.9116 - 3.4173 0.99 1797 155 0.1593 0.2108 REMARK 3 4 3.4173 - 3.1050 0.95 1724 148 0.1952 0.2512 REMARK 3 5 3.1050 - 2.8825 0.85 1548 127 0.2163 0.2683 REMARK 3 6 2.8825 - 2.7125 0.83 1478 128 0.2131 0.2991 REMARK 3 7 2.7125 - 2.5767 0.84 1491 138 0.2094 0.3018 REMARK 3 8 2.5767 - 2.4646 0.82 1472 126 0.2108 0.2963 REMARK 3 9 2.4646 - 2.3697 0.82 1458 125 0.2104 0.3391 REMARK 3 10 2.3697 - 2.2879 0.84 1496 122 0.2047 0.2729 REMARK 3 11 2.2879 - 2.2164 0.86 1513 136 0.2063 0.2593 REMARK 3 12 2.2164 - 2.1530 0.83 1481 122 0.2099 0.2838 REMARK 3 13 2.1530 - 2.0964 0.82 1452 128 0.2300 0.2850 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.680 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.72 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2938 REMARK 3 ANGLE : 0.914 3950 REMARK 3 CHIRALITY : 0.057 424 REMARK 3 PLANARITY : 0.004 488 REMARK 3 DIHEDRAL : 18.269 1774 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5J6C COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-APR-16. REMARK 100 THE DEPOSITION ID IS D_1000220025. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-JUL-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 300K REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25340 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.45400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: HKL-3000, PHASER REMARK 200 STARTING MODEL: 3M5K REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.68 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.26 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M DI-HYDROGEN AMMONIUM CITRATE 20% REMARK 280 PEG 3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.95400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.94100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.36600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.94100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.95400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.36600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -21 REMARK 465 HIS A -20 REMARK 465 HIS A -19 REMARK 465 HIS A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 HIS A -15 REMARK 465 SER A -14 REMARK 465 SER A -13 REMARK 465 GLY A -12 REMARK 465 VAL A -11 REMARK 465 ASP A -10 REMARK 465 LEU A -9 REMARK 465 GLY A -8 REMARK 465 THR A -7 REMARK 465 GLU A -6 REMARK 465 ASN A -5 REMARK 465 LEU A -4 REMARK 465 TYR A -3 REMARK 465 PHE A -2 REMARK 465 GLN A -1 REMARK 465 SER A 0 REMARK 465 MET A 1 REMARK 465 LYS A 2 REMARK 465 GLY A 3 REMARK 465 MET A 4 REMARK 465 ILE A 5 REMARK 465 TYR A 6 REMARK 465 MET B -21 REMARK 465 HIS B -20 REMARK 465 HIS B -19 REMARK 465 HIS B -18 REMARK 465 HIS B -17 REMARK 465 HIS B -16 REMARK 465 HIS B -15 REMARK 465 SER B -14 REMARK 465 SER B -13 REMARK 465 GLY B -12 REMARK 465 VAL B -11 REMARK 465 ASP B -10 REMARK 465 LEU B -9 REMARK 465 GLY B -8 REMARK 465 THR B -7 REMARK 465 GLU B -6 REMARK 465 ASN B -5 REMARK 465 LEU B -4 REMARK 465 TYR B -3 REMARK 465 PHE B -2 REMARK 465 GLN B -1 REMARK 465 SER B 0 REMARK 465 MET B 1 REMARK 465 LYS B 2 REMARK 465 GLY B 3 REMARK 465 MET B 4 REMARK 465 ILE B 5 REMARK 465 TYR B 6 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 359 O HOH B 356 2.13 REMARK 500 N3 IMD A 202 O HOH A 301 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 177 -24.69 69.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FMN A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IMD A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FMN B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IMD B 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5J62 RELATED DB: PDB DBREF 5J6C A 1 179 UNP C9YJL7 C9YJL7_PEPDR 1 179 DBREF 5J6C B 1 179 UNP C9YJL7 C9YJL7_PEPDR 1 179 SEQADV 5J6C MET A -21 UNP C9YJL7 INITIATING METHIONINE SEQADV 5J6C HIS A -20 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C HIS A -19 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C HIS A -18 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C HIS A -17 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C HIS A -16 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C HIS A -15 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C SER A -14 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C SER A -13 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C GLY A -12 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C VAL A -11 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C ASP A -10 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C LEU A -9 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C GLY A -8 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C THR A -7 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C GLU A -6 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C ASN A -5 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C LEU A -4 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C TYR A -3 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C PHE A -2 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C GLN A -1 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C SER A 0 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C MET B -21 UNP C9YJL7 INITIATING METHIONINE SEQADV 5J6C HIS B -20 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C HIS B -19 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C HIS B -18 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C HIS B -17 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C HIS B -16 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C HIS B -15 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C SER B -14 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C SER B -13 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C GLY B -12 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C VAL B -11 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C ASP B -10 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C LEU B -9 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C GLY B -8 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C THR B -7 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C GLU B -6 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C ASN B -5 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C LEU B -4 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C TYR B -3 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C PHE B -2 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C GLN B -1 UNP C9YJL7 EXPRESSION TAG SEQADV 5J6C SER B 0 UNP C9YJL7 EXPRESSION TAG SEQRES 1 A 201 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 201 GLY THR GLU ASN LEU TYR PHE GLN SER MET LYS GLY MET SEQRES 3 A 201 ILE TYR MET ILE GLY PHE LEU LYS LYS ARG ARG SER ILE SEQRES 4 A 201 ARG LYS TYR LYS ASP VAL GLU VAL GLU LYS GLU LYS LEU SEQRES 5 A 201 ASP LYS ILE LEU LYS ALA ALA LEU LEU ALA PRO SER SER SEQRES 6 A 201 LYS GLY LEU ARG THR TRP GLU PHE ILE VAL VAL ASP ASP SEQRES 7 A 201 LYS GLU LYS LEU ILE ASN LEU SER GLN CYS ARG THR LYS SEQRES 8 A 201 GLY GLY GLY PHE PHE LEU LYS ASN ALA PRO LEU ALA ILE SEQRES 9 A 201 VAL ILE ILE ALA ASP LYS GLU LYS ASN ASP VAL TRP ILE SEQRES 10 A 201 GLU ASP ALA SER ILE ALA ALA SER TYR ILE GLN LEU GLN SEQRES 11 A 201 ALA HIS GLU LEU GLY LEU GLY SER CYS TRP ILE GLN VAL SEQRES 12 A 201 ARG ASN ARG MET TYR ASP ASP ASN ILE GLU ALA ASP LYS SEQRES 13 A 201 TYR ILE ARG GLU GLU LEU LYS VAL PRO SER LYS TYR SER SEQRES 14 A 201 VAL GLU CYS ILE ILE SER ILE GLY TYR SER ASP GLU GLU SEQRES 15 A 201 LYS LYS ALA TYR ASN ASP SER ASP LEU ASP TYR LYS LYS SEQRES 16 A 201 VAL HIS PHE ASN ASN PHE SEQRES 1 B 201 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 201 GLY THR GLU ASN LEU TYR PHE GLN SER MET LYS GLY MET SEQRES 3 B 201 ILE TYR MET ILE GLY PHE LEU LYS LYS ARG ARG SER ILE SEQRES 4 B 201 ARG LYS TYR LYS ASP VAL GLU VAL GLU LYS GLU LYS LEU SEQRES 5 B 201 ASP LYS ILE LEU LYS ALA ALA LEU LEU ALA PRO SER SER SEQRES 6 B 201 LYS GLY LEU ARG THR TRP GLU PHE ILE VAL VAL ASP ASP SEQRES 7 B 201 LYS GLU LYS LEU ILE ASN LEU SER GLN CYS ARG THR LYS SEQRES 8 B 201 GLY GLY GLY PHE PHE LEU LYS ASN ALA PRO LEU ALA ILE SEQRES 9 B 201 VAL ILE ILE ALA ASP LYS GLU LYS ASN ASP VAL TRP ILE SEQRES 10 B 201 GLU ASP ALA SER ILE ALA ALA SER TYR ILE GLN LEU GLN SEQRES 11 B 201 ALA HIS GLU LEU GLY LEU GLY SER CYS TRP ILE GLN VAL SEQRES 12 B 201 ARG ASN ARG MET TYR ASP ASP ASN ILE GLU ALA ASP LYS SEQRES 13 B 201 TYR ILE ARG GLU GLU LEU LYS VAL PRO SER LYS TYR SER SEQRES 14 B 201 VAL GLU CYS ILE ILE SER ILE GLY TYR SER ASP GLU GLU SEQRES 15 B 201 LYS LYS ALA TYR ASN ASP SER ASP LEU ASP TYR LYS LYS SEQRES 16 B 201 VAL HIS PHE ASN ASN PHE HET FMN A 201 31 HET IMD A 202 5 HET FMN B 201 31 HET IMD B 202 5 HETNAM FMN FLAVIN MONONUCLEOTIDE HETNAM IMD IMIDAZOLE HETSYN FMN RIBOFLAVIN MONOPHOSPHATE FORMUL 3 FMN 2(C17 H21 N4 O9 P) FORMUL 4 IMD 2(C3 H5 N2 1+) FORMUL 7 HOH *122(H2 O) HELIX 1 AA1 MET A 7 LYS A 13 1 7 HELIX 2 AA2 GLU A 26 LEU A 39 1 14 HELIX 3 AA3 SER A 42 LEU A 46 5 5 HELIX 4 AA4 ASP A 56 GLN A 65 1 10 HELIX 5 AA5 GLY A 72 ALA A 78 5 7 HELIX 6 AA6 VAL A 93 LEU A 112 1 20 HELIX 7 AA7 GLU A 131 LYS A 141 1 11 HELIX 8 AA8 ASN A 165 LEU A 169 5 5 HELIX 9 AA9 ASP A 170 LYS A 172 5 3 HELIX 10 AB1 ILE B 8 LYS B 13 1 6 HELIX 11 AB2 GLU B 26 LEU B 39 1 14 HELIX 12 AB3 SER B 42 LEU B 46 5 5 HELIX 13 AB4 ASP B 56 GLN B 65 1 10 HELIX 14 AB5 GLY B 72 ALA B 78 5 7 HELIX 15 AB6 VAL B 93 LEU B 112 1 20 HELIX 16 AB7 GLU B 131 LEU B 140 1 10 HELIX 17 AB8 ASN B 165 LEU B 169 5 5 HELIX 18 AB9 ASP B 170 LYS B 172 5 3 SHEET 1 AA1 5 GLY A 115 GLN A 120 0 SHEET 2 AA1 5 TYR A 146 GLY A 155 -1 O GLY A 155 N GLY A 115 SHEET 3 AA1 5 LEU A 80 ASP A 87 -1 N ILE A 82 O ILE A 152 SHEET 4 AA1 5 TRP A 49 VAL A 54 -1 N VAL A 54 O ALA A 81 SHEET 5 AA1 5 VAL B 174 PHE B 176 1 O HIS B 175 N VAL A 53 SHEET 1 AA2 5 VAL A 174 PHE A 176 0 SHEET 2 AA2 5 TRP B 49 VAL B 54 1 O VAL B 53 N HIS A 175 SHEET 3 AA2 5 LEU B 80 ASP B 87 -1 O VAL B 83 N ILE B 52 SHEET 4 AA2 5 TYR B 146 GLY B 155 -1 O CYS B 150 N ILE B 84 SHEET 5 AA2 5 GLY B 115 GLN B 120 -1 N GLY B 115 O GLY B 155 SITE 1 AC1 23 ARG A 14 ARG A 15 SER A 16 ARG A 18 SITE 2 AC1 23 ARG A 67 GLY A 71 PHE A 74 CYS A 117 SITE 3 AC1 23 TRP A 118 ILE A 119 GLN A 120 TYR A 164 SITE 4 AC1 23 HOH A 308 HOH A 327 HOH A 331 HOH A 357 SITE 5 AC1 23 PRO B 41 SER B 42 SER B 43 GLY B 45 SITE 6 AC1 23 GLU B 96 ILE B 100 IMD B 202 SITE 1 AC2 6 SER A 43 LYS A 44 HOH A 301 HOH A 307 SITE 2 AC2 6 FMN B 201 HOH B 350 SITE 1 AC3 21 PRO A 41 SER A 42 SER A 43 GLY A 45 SITE 2 AC3 21 GLU A 96 ILE A 100 IMD A 202 ARG B 14 SITE 3 AC3 21 ARG B 15 SER B 16 ARG B 18 ARG B 67 SITE 4 AC3 21 GLY B 71 PHE B 74 CYS B 117 TRP B 118 SITE 5 AC3 21 ILE B 119 GLN B 120 TYR B 164 HOH B 332 SITE 6 AC3 21 HOH B 343 SITE 1 AC4 6 FMN A 201 LYS B 44 HOH B 301 HOH B 355 SITE 2 AC4 6 HOH B 356 HOH B 360 CRYST1 67.908 70.732 87.882 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014726 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014138 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011379 0.00000